| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 |
Aura Biosciences Inc
AURA
|
BUY |
$25.00
Est. +253%
|
$7.08 | $7.48 |
Miss
|
$6.65
-6.1%
|
| Dec 17, 2024 |
Larimar Therapeutics Inc
LRMR
|
BUY |
$15.00
Est. +250%
|
$4.28 | $5.37 |
Miss
|
$2.76
-35.5%
|
| Nov 05, 2024 |
TG Therapeutics Inc
TGTX
|
BUY |
$55.00
Est. +325%
|
$12.93 | $46.42 |
Miss
|
$61.63
+376.6%
|
| Oct 14, 2024 |
Nyxoah SA
NYXH
|
BUY |
$17.00
Est. +77%
|
$9.60 | $11.87 |
Miss
|
$0.86
-91.0%
|
| Oct 11, 2024 |
Inhibikase Therapeutics Inc
IKT
|
BUY |
$5.00
Est. +252%
|
$1.42 | $4.14 |
Miss
|
$1.57
+10.2%
|
| Jul 25, 2024 |
Aura Biosciences Inc
AURA
|
BUY |
$21.00
Est. +127%
|
$9.27 | $12.38 |
Miss
|
$6.65
-28.3%
|
| Jul 01, 2024 |
Valneva SE - ADR
VALN
|
BUY |
$26.00
Est. +252%
|
$7.39 | $8.66 |
Miss
|
$5.70
-22.9%
|
| Jun 28, 2024 |
Dynavax Technologies Corp.
DVAX
|
BUY |
$29.00
Est. +155%
|
$11.37 | $14.63 |
Miss
|
$15.50
+36.3%
|
| Jun 25, 2024 |
G1 Therapeutics Inc
GTHX
|
BUY |
$3.00
Est. +35%
|
$2.22 | $7.19 |
Target Met
|
$7.16
+222.5%
|
| May 24, 2024 |
Nyxoah SA
NYXH
|
BUY |
$18.00
Est. +116%
|
$8.33 | $11.87 |
Miss
|
$0.86
-89.7%
|
| May 16, 2024 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$28.00
Est. +5%
|
$26.72 | $21.01 |
Miss
|
$12.49
-53.3%
|
| May 03, 2024 |
TG Therapeutics Inc
TGTX
|
BUY |
$49.00
Est. +198%
|
$16.42 | $46.42 |
Miss
|
$61.63
+275.3%
|
| Apr 16, 2024 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$29.00
Est. +64%
|
$17.63 | $21.01 |
Miss
|
$12.49
-29.2%
|
| Apr 09, 2024 |
Inozyme Pharma Inc
INZY
|
BUY |
$14.00
Est. +139%
|
$5.87 | $6.24 |
Miss
|
$4.00
-31.9%
|
| Apr 02, 2024 |
SAB Biotherapeutics Inc
SABS
|
BUY |
$6.00
Est. +40%
|
$4.29 | $5.01 |
Miss
|
$3.18
-25.9%
|
| Dec 29, 2022 |
TG Therapeutics Inc
TGTX
|
BUY |
$24.00
Est. +467%
|
$4.23 | - | - |
$61.63
+1357.0%
|
| Sep 21, 2021 |
Mirati Therapeutics Inc
MRTX
|
BUY |
$247.00
Est. +48%
|
$167.09 | - | - |
$58.70
-64.9%
|